tiprankstipranks
Trending News
More News >
Fineotex Chemical Limited (IN:FCL)
:FCL
India Market
Advertisement

Fineotex Chemical Limited (FCL) AI Stock Analysis

Compare
2 Followers

Top Page

IN:FCL

Fineotex Chemical Limited

(FCL)

Rating:72Outperform
Price Target:
₹299.00
▲(31.17% Upside)
Fineotex Chemical Limited's strong financial performance, characterized by growth and stability, is the most significant factor driving the overall score. Technical analysis presents a neutral outlook, while valuation concerns suggest the stock may be overpriced. The absence of earnings call and corporate events data limits further insights.

Fineotex Chemical Limited (FCL) vs. iShares MSCI India ETF (INDA)

Fineotex Chemical Limited Business Overview & Revenue Model

Company DescriptionFineotex Chemical Limited (FCL) is a leading specialty chemical manufacturer and supplier, primarily serving the textile and garment industries. The company is engaged in the production of a wide range of textile chemicals, auxiliaries, and specialty chemicals that cater to the diverse needs of its clients. With a focus on innovation and sustainability, FCL operates in various sectors including textiles, construction, agriculture, and leather, providing solutions that enhance the performance and quality of end products.
How the Company Makes MoneyFineotex Chemical Limited generates revenue primarily through the sale of its specialty chemicals and auxiliaries used in the textile industry. These chemicals are essential for processes such as pre-treatment, dyeing, printing, and finishing of textiles, making them an integral part of the textile manufacturing chain. The company also diversifies its revenue streams through the supply of chemicals for the construction, agriculture, water treatment, and leather industries. FCL's earnings are further bolstered by strategic partnerships and collaborations with international chemical companies, which enhance its product offerings and market reach. The company's growth is supported by its investment in research and development, allowing it to introduce innovative and sustainable solutions that meet evolving industry demands.

Fineotex Chemical Limited Financial Statement Overview

Summary
Fineotex Chemical Limited shows strong profitability and growth metrics, with a solid income statement and stable balance sheet. The company maintains low leverage and robust equity, though cash flow management requires attention due to recent fluctuations.
Income Statement
85
Very Positive
Fineotex Chemical Limited has demonstrated robust revenue growth with a significant increase from 2020 to 2025. The company maintained a strong gross profit margin, consistently above 30%, and an improving net profit margin, indicating efficient cost management. Despite a slight dip in revenue in the latest year, the overall performance showcases resilience and profitability, making the income statement solid.
Balance Sheet
80
Positive
The balance sheet of Fineotex Chemical Limited reflects a healthy financial position with low debt levels and a growing stockholders' equity, resulting in a very low debt-to-equity ratio. The equity ratio remains strong, highlighting financial stability. However, the lower cash reserves in the latest year could pose a risk if not managed carefully.
Cash Flow
75
Positive
Cash flow analysis shows variability, with a recent decline in free cash flow due to increased capital expenditures. The operating cash flow to net income ratio indicates strong cash generation capabilities, although the fluctuation in free cash flow suggests potential liquidity challenges if investment activities continue to rise.
BreakdownMar 2025Mar 2023Mar 2024Mar 2022Mar 2021
Income Statement
Total Revenue5.33B5.17B5.69B3.67B2.17B
Gross Profit2.06B1.78B2.17B1.30B757.73M
EBITDA1.27B1.13B1.65B719.00M424.05M
Net Income1.08B883.16M1.20B551.74M425.88M
Balance Sheet
Total Assets8.15B4.22B5.48B3.39B2.67B
Cash, Cash Equivalents and Short-Term Investments416.97M611.90M735.06M308.35M279.33M
Total Debt2.17M72.80M51.90M19.08M34.76M
Total Liabilities757.59M659.02M945.90M700.96M509.90M
Stockholders Equity7.31B3.49B4.47B2.62B2.09B
Cash Flow
Free Cash Flow-73.46M887.62M494.76M-91.37M-149.48M
Operating Cash Flow693.34M1.08B973.81M133.75M92.59M
Investing Cash Flow-2.73B-1.03B-468.50M-7.44M-65.32M
Financing Cash Flow1.76B-64.39M-239.11M-56.59M-44.42M

Fineotex Chemical Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price227.95
Price Trends
50DMA
265.86
Negative
100DMA
253.15
Negative
200DMA
284.11
Negative
Market Momentum
MACD
-10.09
Positive
RSI
33.14
Neutral
STOCH
12.12
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FCL, the sentiment is Negative. The current price of 227.95 is below the 20-day moving average (MA) of 257.77, below the 50-day MA of 265.86, and below the 200-day MA of 284.11, indicating a bearish trend. The MACD of -10.09 indicates Positive momentum. The RSI at 33.14 is Neutral, neither overbought nor oversold. The STOCH value of 12.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:FCL.

Fineotex Chemical Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (56)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
₹26.63B16.89
0.85%11.21%27.69%
72
Outperform
₹26.12B23.92
0.35%-8.66%-17.63%
63
Neutral
₹32.02B46.83
0.73%19.59%13.81%
61
Neutral
₹29.80B15.84
-2.60%83.16%
56
Neutral
£2.53B6.27-0.23%46.00%10.12%5.01%
48
Neutral
₹29.19B
0.35%-1.61%-18.85%
43
Neutral
₹21.72B
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:FCL
Fineotex Chemical Limited
236.55
-114.20
-32.56%
IN:KIRIINDUS
Kiri Industries Limited
530.65
198.90
59.95%
IN:MANINDS
Man Industries (India) Limited
396.10
-41.55
-9.49%
IN:MOL
Meghmani Organics Limited
83.39
-3.85
-4.41%
IN:RAMRAT
Ram Ratna Wires Limited
690.90
250.85
57.00%
IN:TIRUMALCHM
Thirumalai Chemicals Limited
286.55
-27.50
-8.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 26, 2025